Prognostic Value Of Disease Status At Time Of Allogeneic Transplant For Relapsed Non-Hodgkin's Lymphoma

被引：0
|
作者：
Bakhos, Shams
Aleah, Brubaker L.
Parthasarathy, Mala
Go, Aileen
Rodriguez, Tulio E.
Stiff, Patrick J.
Smith, Scott E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3412.3412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3412
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [32] Spontaneous regression of relapsed non-Hodgkin’s lymphoma in a patient who received an autologous transplant for primary resistant disease
    ID Lewis
    LB To
    Bone Marrow Transplantation, 1997, 20 : 251 - 253
  • [33] Efficiency of Nivolumab in Children with Refractory and Relapsed Hodgkin's and Non-Hodgkin's Lymphoma
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Kazantzev, I.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Mikhailova, N.
    Zubarovskaya, L.
    Afanasyev, B.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S202 - S203
  • [34] Spontaneous regression of relapsed non-Hodgkin's lymphoma in a patient who received an autologous transplant for primary resistant disease
    Lewis, ID
    To, LB
    BONE MARROW TRANSPLANTATION, 1997, 20 (03) : 251 - 253
  • [35] Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
    Rezvani, Andrew R.
    Storer, Barry
    Maris, Michael
    Sorror, Mohamed L.
    Agura, Edward
    Maziarz, Richard T.
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Lange, Thoralf
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael A.
    Sandmaier, Brenda M.
    Storb, Rainer
    Maloney, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 211 - 217
  • [36] The prognostic value of body mass index in Hodgkin lymphoma and diffuse non-Hodgkin lymphoma.
    Turgut, Mehmet
    Kelkitli, Engin
    Atay, Memis Hilmi
    Cilingir, Fatih Mehmet
    Yilmaz, Bahiddin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis
    He, Chuan
    Liu, Zhigang
    Ji, Jie
    Zhu, Huanling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 5847 - 5854
  • [38] Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma
    Juneja, S
    Matthews, J
    Lukeis, R
    Laidlaw, C
    Cooper, I
    Wolf, M
    Ironside, P
    Garson, OM
    LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 493 - 501
  • [39] THE SURVIVAL OF RELAPSED/REFRACTORY PATIENTS WITH HODGKIN'S LYMPHOMA TREATED WITH ALLOGENEIC TRANSPLANT IS NOT IMPACTED BY THE TIME OF RELAPSE AFTER AUTOLOGOUS TRANSPLANT OR REFRACTORY DISEASE
    Spina, F.
    Dalto, S.
    De Philippis, C.
    Viviani, S.
    Corradini, P.
    HAEMATOLOGICA, 2015, 100 : 7 - 7
  • [40] Whipple's disease and Non-Hodgkin's lymphoma
    Gruner, U
    Goesch, P
    Donner, A
    Peters, U
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (04): : 305 - 309
12345